191 related articles for article (PubMed ID: 36493619)
1. 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy.
Valencia-Lazcano AA; Hassan D; Pourmadadi M; Shamsabadipour A; Behzadmehr R; Rahdar A; Medina DI; Díez-Pascual AM
Eur J Med Chem; 2023 Jan; 246():114995. PubMed ID: 36493619
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
[TBL] [Abstract][Full Text] [Related]
3. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Designing 5-Fluorouracil Delivery Systems: A Stepping Stone in the Safe Treatment of Colorectal Cancer.
Entezar-Almahdi E; Mohammadi-Samani S; Tayebi L; Farjadian F
Int J Nanomedicine; 2020; 15():5445-5458. PubMed ID: 32801699
[TBL] [Abstract][Full Text] [Related]
5. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
7. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
8. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.
Sharma A; Kaur A; Jain UK; Chandra R; Madan J
Colloids Surf B Biointerfaces; 2017 Jul; 155():200-208. PubMed ID: 28431329
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy.
Pourmadadi M; Ghaemi A; Shamsabadipour A; Rajabzadeh-Khosroshahi M; Shaghaghi M; Rahdar A; Pandey S
Eur J Med Chem; 2023 Oct; 258():115547. PubMed ID: 37327678
[TBL] [Abstract][Full Text] [Related]
10. An alternative hybrid lipid nanosystem combining cytotoxic and magnetic properties as a tool to potentiate antitumor effect of 5-fluorouracil.
Azevedo A; Coelho MP; Pinho JO; Soares PIP; Reis CP; Borges JP; Gaspar MM
Life Sci; 2024 May; 344():122558. PubMed ID: 38471621
[TBL] [Abstract][Full Text] [Related]
11. Sulfonamide-Functionalized Polymeric Nanoparticles for Enhanced In Vivo Colorectal Cancer Therapy.
Guimarães PPG; Viana CTR; Pereira L; Gontijo SML; Campos PP; Andrade SP; Santos RAS; Sinisterra RD
Curr Drug Deliv; 2022; 19(6):676-685. PubMed ID: 34325632
[TBL] [Abstract][Full Text] [Related]
12. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy.
Kumari S; Kondapi AK
Int J Biol Macromol; 2017 Feb; 95():232-237. PubMed ID: 27864056
[TBL] [Abstract][Full Text] [Related]
14. Advances of smart nano-drug delivery systems in osteosarcoma treatment.
Liu Y; Li Q; Bai Q; Jiang W
J Mater Chem B; 2021 Jul; 9(27):5439-5450. PubMed ID: 34155495
[TBL] [Abstract][Full Text] [Related]
15. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
[TBL] [Abstract][Full Text] [Related]
16. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer.
Tang Q; Wang Y; Huang R; You Q; Wang G; Chen Y; Jiang Z; Liu Z; Yu L; Muhammad S; Wang X
PLoS One; 2014; 9(6):e98455. PubMed ID: 24896096
[TBL] [Abstract][Full Text] [Related]
17. Functionalized PAMAM-based Nanoformulation for Targeted Delivery of 5-Fluorouracil in Hepatocellular Carcinoma.
Chen S; Ouyang H; He D; Liu D; Wang X; Chen H; Pan W; Li Q; Xie W; Yu C
Curr Pharm Des; 2022; 28(25):2113-2125. PubMed ID: 35524673
[TBL] [Abstract][Full Text] [Related]
18. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.
Ortiz R; Prados J; Melguizo C; Arias JL; Ruiz MA; Alvarez PJ; Caba O; Luque R; Segura A; Aránega A
Int J Nanomedicine; 2012; 7():95-107. PubMed ID: 22275826
[TBL] [Abstract][Full Text] [Related]
19. Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer.
Abd-Rabou AA; Bharali DJ; Mousa SA
Pharm Res; 2018 Feb; 35(4):76. PubMed ID: 29488022
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
